Henry Schein Announces Completion of Strategic Investment by KKR
MELVILLE, N.Y.–(BUSINESS WIRE)– Henry Schein, Inc. (Nasdaq:
HSIC), the world’s largest provider of health care solutions to
office-based dental and medical practitioners, today announced
the successful completion of a $250 million strategic investment
by funds affiliated with KKR, a leading global investment firm.
Upon the closing of this transaction, KKR has become the holder
of approximately 12% of the common shares of Henry Schein.
In connection with the investment, William K. “Dan” Daniel,
Executive Advisor to KKR and former Executive Vice President of
Danaher Corporation, has officially joined Henry Schein’s Board
of Directors as an independent director. He joins Max Lin,
Partner at KKR and leader of the firm’s Health Care industry team
in the Americas, who became a member of Henry Schein’s Board of
Directors on May 2, 2025.
Max Lin leads the Health Care industry team within KKR, and since
joining in 2005, he has overseen a number of investments in the
areas of dental services and other health care providers, medical
products and equipment, and health care software and information
technology. Dan Daniel has over three decades of global
leadership experience in industrial and health care sectors,
including 14 years as Executive Vice President at Danaher, where
he oversaw multiple segments and played a key role in advancing
the company’s culture and business system. In connection with
each of their appointments, Mr. Lin was appointed to the
Nominating and Governance Committee as Vice Chair; Mr. Daniel was
appointed to the Compensation Committee; and each of Mr. Lin and
Mr. Daniel was appointed to the Strategic Advisory Committee.
“We are pleased to welcome Max and Dan to the Board as we embark
on this exciting next chapter for Henry Schein,” said Stanley M.
Bergman, Chairman of the Board and Chief Executive Officer of
Henry Schein. “Their deep experience in health care, operations,
and strategic growth will be invaluable as we continue executing
on our BOLD+1 strategy and creating long-term value for our
stakeholders.”
About Henry Schein, Inc. Henry Schein, Inc. (Nasdaq: HSIC) is a
solutions company for health care professionals powered by a
network of people and technology. With approximately 25,000 Team
Schein Members
<https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%
2Fwww.henryschein.com%2Fus-en%2FCorporate%2FCulture.aspx%3Futm_so
urce%3DCorporate%26utm_medium%3DExternal%26utm_campaign%3DBoilerP
lateLinks%26utm_term%3DTeamScheinMembers%26cdivid%3Dcorporate&esh
eet=54256009&newsitemid=20250516439220&lan=en-US&anchor=Team+Sche
in+Members&index=1&md5=36ce7315256e3d8560640d9d4462c75c>
worldwide, the Company’s network of trusted advisors provides
more than 1 million customers globally with more than 300 valued
solutions that help improve operational success and clinical
outcomes. Our Business, Clinical, Technology, and Supply Chain
solutions help office-based dental
<https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%
2Fwww.henryschein.com%2Fus-en%2Fdental%2FDefault.aspx%3Fdid%3Dden
tal%26stay%3D1%26utm_source%3DCorportate%26utm_medium%3DExternal%
26utm_campaign%3DBoilerPlateLinks%26utm_term%3Ddental%26cdivid%3D
dental&esheet=54256009&newsitemid=20250516439220&lan=en-US&anchor
=dental&index=2&md5=728bf6e6fdd68766947b7ccfb0719f90> and
medical
<https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%
2Fwww.henryschein.com%2Fus-en%2Fmedical%2Fdefault.aspx%3Fdid%3Dme
dical%26stay%3D1%26utm_source%3DCorportate%26utm_medium%3DExterna
l%26utm_campaign%3DBoilerPlateLinks%26utm_term%3Dmedical%26cdivid
%3Dmedical&esheet=54256009&newsitemid=20250516439220&lan=en-US&an
chor=medical&index=3&md5=68c0c90f009c7935e04f35ab74ac88b0>
practitioners work more efficiently so they can provide quality
care more effectively. These solutions also support dental
laboratories
<https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%
2Fwww.henryschein.com%2Fus-en%2Fzahn%2Fhome.aspx%3Futm_source%3DC
orporate%26utm_medium%3DExternal%26utm_campaign%3DBoilerPlateLink
s%26utm_term%3DZahn%26cdivid%3Dzahn&esheet=54256009&newsitemid=20
250516439220&lan=en-US&anchor=dental+laboratories&index=4&md5=f63
680178b0f9d7677da07d142764d56> , government and institutional
health care clinics
<https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%
2Fwww.henryschein.com%2Fus-en%2Fspecialmarkets%2FDefault.aspx%3Fu
tm_source%3DCorporate%26utm_medium%3DExternal%26utm_campaign%3DBo
ilerPlateLinks%26utm_term%3DGovernmentInstitutional%26cdivid%3Dsp
ecialmarkets_d&esheet=54256009&newsitemid=20250516439220&lan=en-U
S&anchor=government+and+institutional+health+care+clinics&index=5
&md5=5ab73ff4c7e66163b58e29633e00725e> , as well as other
alternate care sites.
Henry Schein operates through a centralized and automated
distribution network, with a selection of more than 300,000
branded products and Henry Schein corporate brand products in our
distribution centers.
A FORTUNE 500 Company and a member of the S&P 500(r) index, Henry
Schein is headquartered in Melville, N.Y., and has operations or
affiliates in 33 countries and territories. The Company’s sales
reached $12.7 billion in 2024, and have grown at a compound
annual rate of approximately 11.2 percent since Henry Schein
became a public company in 1995.
For more information, visit Henry Schein at www.henryschein.com
<https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%
2Fwww.henryschein.com%2Fus-en%2FGlobal.aspx%3Futm_source%3DCorpor
ate%26utm_medium%3DExternal%26utm_campaign%3DBoilerPlateLinks%26u
tm_term%3DHenrySchein%26cdivid%3Dcorporate&esheet=54256009&newsit
emid=20250516439220&lan=en-US&anchor=www.henryschein.com&index=6&
md5=13be9c3cb84286d48ea4ccad48d81b79> , Facebook.com/HenrySchein
<https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2
Fwww.facebook.com%2Fhenryschein&esheet=54256009&newsitemid=202505
16439220&lan=en-US&anchor=Facebook.com%2FHenrySchein&index=7&md5=
766f96ab5292ae4a9233b2e084c5220d> , Instagram.com/HenrySchein
<https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2
Fwww.instagram.com%2Fhenryschein&esheet=54256009&newsitemid=20250
516439220&lan=en-US&anchor=Instagram.com%2FHenrySchein&index=8&md
5=9976ccf0bdc2a4b9cf6a25df2905db6a> ,
LinkedIn.com/Company/HenrySchein,
<https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%
2Fwww.linkedin.com%2Fcompany%2Fhenry-schein%2F&esheet=54256009&ne
wsitemid=20250516439220&lan=en-US&anchor=LinkedIn.com%2FCompany%2
FHenrySchein%2C&index=9&md5=167d619defa2ae9d72fc3b4960222806>
and @HenrySchein on X
<https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2
Fwww.twitter.com%2Fhenryschein&esheet=54256009&newsitemid=2025051
6439220&lan=en-US&anchor=%40HenrySchein+on+X&index=10&md5=198f205
cad9b5c638e5296691954a1c0> .
About KKR KKR is a leading global investment firm that offers
alternative asset management as well as capital markets and
insurance solutions. KKR aims to generate attractive investment
returns by following a patient and disciplined investment
approach, employing world-class people, and supporting growth in
its portfolio companies and communities. KKR sponsors investment
funds that invest in private equity, credit and real assets and
has strategic partners that manage hedge funds. KKR’s insurance
subsidiaries offer retirement, life and reinsurance products
under the management of Global Atlantic Financial Group.
References to KKR’s investments may include the activities of its
sponsored funds and insurance subsidiaries. For additional
information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s
website at www.kkr.com
<https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2
Fwww.kkr.com&esheet=54256009&newsitemid=20250516439220&lan=en-US&
anchor=www.kkr.com&index=11&md5=bd6deaf3fab2cbc8d17e3b18e2e338a9>
. For additional information about Global Atlantic Financial
Group, please visit Global Atlantic Financial Group’s website at
www.globalatlantic.com
<https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2
Fwww.globalatlantic.com&esheet=54256009&newsitemid=20250516439220
&lan=en-US&anchor=www.globalatlantic.com&index=12&md5=c3e1f32b48e
700ecf3f48fa817b43bbc> .
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
